We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

PAREXEL Expands Perceptive® Partner Program

News   Sep 17, 2014

 
PAREXEL Expands Perceptive® Partner Program
 
 
Advertisement
 

RELATED ARTICLES

Platinum-based Chemo May Improve Survival in Certain Metastatic Pancreatic Cancer Patients

News

Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy, compared with patients that did not have these mutations, according to a new study.

READ MORE

Not Enough Women and Older Adults in Cholesterol Drug Trials, Study Suggests

News

Johns Hopkins Medicine researchers report that although some progress has been made — women and older adults are still underrepresented in lipid lowering therapy trials compared with their disease burden.

READ MORE

Increased Ventricular Arrhythmias and No Improvement in Death Rate for COVID-19 Patients Who Received Hydroxychloroquine

News

A research team led by investigators from Brigham and Women’s Hospital has evaluated real-world evidence related to outcomes for COVID-19 patients who were treated with hydroxychloroquine or chloroquine analogues (with or without a macrolide). The research findings are published in The Lancet.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE